Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Lifts full-year outlook as obesity drug boom accelerates
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The transaction marks a clear portfolio reshuffle for Indoco
Subscribe To Our Newsletter & Stay Updated
